The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
Publication
, Journal Article
Friedewald, VE; Ballantyne, CM; Davidson, MH; Guyton, JR; Roberts, WC
Published in: Am J Cardiol
September 1, 2008
Duke Scholars
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
September 1, 2008
Volume
102
Issue
5
Start / End Page
559 / 567
Location
United States
Related Subject Headings
- United States
- Risk Factors
- Outcome Assessment, Health Care
- Morbidity
- Lipids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Friedewald, V. E., Ballantyne, C. M., Davidson, M. H., Guyton, J. R., & Roberts, W. C. (2008). The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk. Am J Cardiol, 102(5), 559–567. https://doi.org/10.1016/j.amjcard.2008.06.028
Friedewald, Vincent E., Christie M. Ballantyne, Michael H. Davidson, John R. Guyton, and William C. Roberts. “The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.” Am J Cardiol 102, no. 5 (September 1, 2008): 559–67. https://doi.org/10.1016/j.amjcard.2008.06.028.
Friedewald VE, Ballantyne CM, Davidson MH, Guyton JR, Roberts WC. The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk. Am J Cardiol. 2008 Sep 1;102(5):559–67.
Friedewald, Vincent E., et al. “The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.” Am J Cardiol, vol. 102, no. 5, Sept. 2008, pp. 559–67. Pubmed, doi:10.1016/j.amjcard.2008.06.028.
Friedewald VE, Ballantyne CM, Davidson MH, Guyton JR, Roberts WC. The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk. Am J Cardiol. 2008 Sep 1;102(5):559–567.
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
September 1, 2008
Volume
102
Issue
5
Start / End Page
559 / 567
Location
United States
Related Subject Headings
- United States
- Risk Factors
- Outcome Assessment, Health Care
- Morbidity
- Lipids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- 3201 Cardiovascular medicine and haematology